Hugel partners with Korean Academy of Anti-Aging Dermatology to develop global standards for botulinum toxin treatment and enhance medical education through webinars and protocols.
Hugel reports record 2025 revenue of 425.1 billion won
Hugel reported record 2025 revenue of 425.1 billion won, up 14% year-over-year. Operating profit rose 21.3% to 201.6 billion won. Growth driven by global expansion of botulinum toxin and filler products.
Hugel conducts 'Letybo' brand education for Brazilian medical professionals
Hugel conducted a 3-day seminar for 60 Brazilian dermatologists to enhance understanding of Letybo brand, including clinic visits, factory tour, and networking sessions.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.